Catalyst
Slingshot members are tracking this event:
Synergy (SGYP) Announces Phase 3 Results Analyzing TRULANCE (Plecanatide) in Adults with Chronic Idiopathic Constipation (CIC) in the American Journal of Gastroenterology
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SGYP |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 07, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Trulance, Plecanatide, Chronic Idiopathic Constipation, Cic, American Journal Of Gastroenterology, Phase 3
